Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF vs rhG-CSF for prevention of chemotherapy-induced neutropenia
CTR20130493Phase 2Active
- Sponsor
- Jiuyuan Gene Engineering
- Start
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Jiuyuan Gene Engineering. Started Oct 2013; status: active.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on CTR20130493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130493.